| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 01/15/2009 | US20090016964 Hyperpolarization methods, systems and compositions |
| 01/15/2009 | US20090016963 Genes involved in neurodegenerative conditions |
| 01/15/2009 | US20090016962 Compositions and methods for the treatment of cancer |
| 01/15/2009 | US20090016961 Stem Cell Fusion Model of Carcinogenesis |
| 01/15/2009 | US20090016960 System and method for using glass microspheres containing a positron-emitting isotope to image blood flow and distribute a radiomedical treatment species |
| 01/15/2009 | US20090016959 Drug delivery across the blood-brain barrier using polypeptides; neurological diseases; aprotinin |
| 01/15/2009 | US20090016957 Polypeptides |
| 01/15/2009 | US20090016956 Labeled Macrophages and Methods of Use Thereof |
| 01/15/2009 | CA2692646A1 Contrast agents |
| 01/14/2009 | EP2014310A2 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
| 01/14/2009 | EP2014286A2 Cremophor free epothilone particles coated with protein for treating cancer |
| 01/14/2009 | EP2012937A2 Systems and methods for producing multilayered particles, fibers and sprays and methods for administering the same |
| 01/14/2009 | EP2012832A2 Methods for assessing cell labeling |
| 01/14/2009 | EP2012831A2 Nanogel contrast agents for optical molecular imaging |
| 01/14/2009 | EP1509254B1 New agents for magnetic imaging method |
| 01/14/2009 | EP1349490B1 Fluorescence-mediated molecular tomography |
| 01/14/2009 | EP1311241B1 Use of a porous carrier |
| 01/14/2009 | EP1297142B1 Dual specificity antibodies and methods of making and using |
| 01/14/2009 | EP1146913B1 Conjugates of granulocyte colony stimulating factors for targeting and imaging infection and inflammation |
| 01/14/2009 | CN101342372A Use of pancreatic lipase associated protein 1 |
| 01/14/2009 | CN100452254C Ferroferric oxide magnetic fluid and its preparing method and use |
| 01/14/2009 | CN100450996C Blood pool agents for nuclear magnetic resonance diagnostics |
| 01/13/2009 | US7476740 Monoamine transporter inhibitors; used for early diagnosis and treatment of neurological and psychiatric conditions |
| 01/13/2009 | US7476659 Especially a chitosan in which the amine group is substituted with a photocurable carbonylazide, sulfonylazide, aromatic azide, or formyl styryl group and irradiating with light during surgery to form an insoluble hydrogel |
| 01/13/2009 | US7476526 Protein for use in generating resistance to bactericides in cells |
| 01/08/2009 | WO2009006146A1 Macrophage-enhanced mri (memri) |
| 01/08/2009 | WO2009006046A1 Dendrimer conjugates of agonists and antagonists of the gpcr superfamily |
| 01/08/2009 | WO2009005752A1 Stabilized gold nanoparticle and contrast agent |
| 01/08/2009 | WO2009005365A1 Contrast agents |
| 01/08/2009 | WO2009005364A1 Contrast agents |
| 01/08/2009 | WO2009004914A1 Pet probe having alkoxy group substituted by fluorine and hydroxy group |
| 01/08/2009 | WO2009004357A2 A method of hyperpolarising a magnetic resonance agent |
| 01/08/2009 | WO2008100328A3 METHODS AND COMPOSITIONS FOR TARGETING gC1qR/p32 |
| 01/08/2009 | WO2008089738A3 Ferrous oxide-binding peptides |
| 01/08/2009 | WO2006078979A3 Vectors and methods for genetic immunization |
| 01/08/2009 | US20090013420 Psmcs as Modifiers of the Rb Pathway and Methods of Use |
| 01/08/2009 | US20090013418 Trophectodermal Cell-Specific Gene Transfer Methods |
| 01/08/2009 | US20090013416 Pdes as modifiers of the igfr pathways and methods of use |
| 01/08/2009 | US20090010930 Antibodies to vla-1 |
| 01/08/2009 | US20090010853 Contrast agents |
| 01/08/2009 | US20090010851 Fluorescent Pyrazine Derivatives and Methods of Using the Same in Assessing Renal Function |
| 01/08/2009 | US20090010850 Formulations and methods for treating dry eye |
| 01/08/2009 | US20090010849 Methods of screening an agent for an activity in an isolated eye of a teleost |
| 01/08/2009 | US20090010848 Recombinant Peptides Derived from the Mc3 Anti-BA46 Antibody, Methods of Use Thereof, and Methods of Humanizing Antibody Peptides |
| 01/08/2009 | US20090010845 Polybiotin Compounds of Magnetic Resonance Imaging and Drug Delivery |
| 01/08/2009 | US20090010844 Imaging Infection With Compounds That Bind to Thymidine Kinase |
| 01/08/2009 | US20090010840 BISPECIFIC SINGLE CHAIN Fv ANTIBODY MOLECULES AND METHODS OF USE THEREOF |
| 01/08/2009 | US20090010839 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 01/08/2009 | CA2699965A1 Pet probe having an alkoxy group substituted by fluorine and hydroxy group |
| 01/08/2009 | CA2691664A1 Macrophage-enhanced mri (memri) |
| 01/07/2009 | EP2011519A1 Process and apparatus for preparing a diagnostic or therapeutic agent |
| 01/07/2009 | EP2011518A1 Test agent for diagnosing dyspepsia |
| 01/07/2009 | EP2010646A2 Cellular labeling and quantification for nuclear magnetic resonance techniques |
| 01/07/2009 | EP2010210A2 Vaccine for avian influenza and methods of use |
| 01/07/2009 | EP2010152A1 Magnetic nanoparticles compositions and uses thereof |
| 01/07/2009 | EP2010063A2 Patch and uses thereof |
| 01/07/2009 | EP2009990A2 Methods and compositions related to adenoassociated virus-phage particles |
| 01/07/2009 | EP1496942B1 Microparticles comprising carbohydrate beads covalently linked with allergen derived from plant pollen |
| 01/07/2009 | EP1341521B1 Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers |
| 01/07/2009 | EP1012293B1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 01/07/2009 | EP0966537B1 Fasciola hepatica vaccines |
| 01/07/2009 | EP0759985B1 Transgenic arthritic mice |
| 01/07/2009 | CN101341119A Higher fatty acid triester and amide derivative having diethylenetriamine-type metal chelate structure |
| 01/07/2009 | CN101340900A Nanoscale particles used as contrasting agents in magnetic resonance imaging |
| 01/07/2009 | CN101337907A Process for purifying ioversol |
| 01/07/2009 | CN101337079A Process and apparatus for preparing a diagnostic or therapeutic agent |
| 01/07/2009 | CN101337078A Production method of magnetic resonance imaging contrast agent |
| 01/07/2009 | CN101337077A Preparation method of skin spot pricking method diagnosis lung acariasis antigen liquid |
| 01/06/2009 | US7473761 Therapy for metabolic disorders; polycystic kidney diseasel diarrhea; gastrointestinal disorders |
| 01/06/2009 | US7473527 Compounds promoting delivery of genes |
| 01/06/2009 | US7473415 Near infrared fluorescent contrast agent and method for fluorescence imaging |
| 01/06/2009 | US7473414 Using wound healing agent to repair injured nervous system tissues; gene therapy; animal models; tissue regeneration |
| 01/06/2009 | CA2267244C Methods for treating urinary incontinence in mammals |
| 01/06/2009 | CA2214778C Process for the production of polymeric microparticles, microparticles that are produced according to this process as well as their use in medical diagnosis |
| 01/06/2009 | CA2149770C Detection of hypoxia |
| 01/02/2009 | DE102005007223B4 Verwendung eines endohedrale Fullerene enthaltendes Kontrastmittel für die Kernspintomographie unter Nutzung des Overhauser-Effekts Endohedral fullerenes containing the use of a contrast agent for magnetic resonance imaging using the Overhauser effect |
| 01/01/2009 | US20090005763 Implantable Devices and Methods for Delivering Drugs and Other Substances to Treat Sinusitis and Other Disorders |
| 01/01/2009 | US20090004119 Polymers |
| 01/01/2009 | US20090004118 Multifunctional Nanoparticle Conjugates And Their Use |
| 01/01/2009 | US20090004117 Self-Illiminating Dot Systems and Methods of Use Thereof |
| 01/01/2009 | US20090004116 In vivo optical imaging |
| 01/01/2009 | US20090004115 In vivo cell trafficking |
| 01/01/2009 | US20090004114 System and Method for Monitoring in Vivo Drug Release Using Overhauser-Enhanced Nmr |
| 01/01/2009 | US20090004113 Macrophage-Enhanced MRI (MEMRI) |
| 01/01/2009 | US20090004112 Methods for the treatment of neurodegenerative diseases using nmda receptor glycine site antagonists |
| 01/01/2009 | US20090004111 Structure of the Hepatitis C Ns5a Protein |
| 01/01/2009 | US20090004110 Multi-functional gelatin particle and its use |
| 01/01/2009 | US20090004109 Antibodies and Molecules Derived Therefrom that Bind to Steap-1 Proteins |
| 01/01/2009 | US20090004108 Smmr (Small Molecule Metabolite Reporters) For Use As In Vivo Glucose Biosensors |
| 01/01/2009 | US20090004104 Methods and Compositions for Delivering Active Agents with Enhanced Pharmacological Properties |
| 01/01/2009 | US20090004102 HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| 01/01/2009 | US20090004101 Method and Means for Enhanced Pulmonary Drug Delivery |
| 12/31/2008 | WO2009000777A2 Imaging diagnostics by combining contrast agents |
| 12/31/2008 | WO2008108941A3 Integrated photoactive peptides and uses thereof |
| 12/31/2008 | WO2008095450A3 Negative contrast agent for mri comprising a water suspension of clay and iron oxide nanoparticles |
| 12/31/2008 | WO2006107745A3 Composition for treatment of menopause |
| 12/31/2008 | EP2009119A1 Compositions for treating cancer using viruses |
| 12/31/2008 | EP2007434A2 Method and system for determining whether a drug will be effective on a patient with a disease |
| 12/31/2008 | EP2007206A2 Method and composition for protecting neuronal tissue from damage induced by elevated glutamine levels |
| 12/31/2008 | EP1487343B1 Biospecific contrast agents |